Skip to main content

7 Result(s)

within Medicine & Public Health Remove this filter Internal Medicine Remove this filter Medicine/Public Health, general Remove this filter Public Health Remove this filter N. Salooja Remove this filter

and

  1. Article

    Open Access

    Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study

    Metabolic syndrome (MetS) is associated with cardiovascular disease in the general population and is also a potential cardiovascular risk factor in survivors of haematopoietic cell transplantation (HCT). We re...

    D. M. Greenfield, N. Salooja, C. Peczynski, S. van der Werf… in Bone Marrow Transplantation (2021)

    Download PDF (758 KB) View Article

  2. No Access

    Article

    Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes

    Despite international guidelines, optimal delivery models of late effects (LE) services for HSCT patients are unclear from the clinical, organizational and economic viewpoints. To scope current LE service deli...

    A Hamblin, D M Greenfield, M Gilleece, N Salooja, M Kenyon… in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

    Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus and all cause mortality. Long-term survivors of hematopoietic ce...

    Z DeFilipp, R F Duarte, J A Snowden, N S Majhail… in Bone Marrow Transplantation (2017)

  4. No Access

    Article

    Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters

    Younger children are considered to be more vulnerable to late effects (LE), which prompted us to study LE in patients after haematopoietic stem cell transplantation (HSCT) for a haematological malignancy befor...

    D Bresters, A Lawitschka, C Cugno, U Pötschger, A Dalissier… in Bone Marrow Transplantation (2016)

  5. No Access

    Article

    Secondary solid cancer screening following hematopoietic cell transplantation

    Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of develo** secondary solid cancers, particularly beyond 5 years after HCT and without reaching a plateau overtime. A working group...

    Y Inamoto, N N Shah, B N Savani, B E Shaw, A A Abraham… in Bone Marrow Transplantation (2015)

  6. No Access

    Article

    Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT

    A Rovó, M Aljurf, S Chiodi, S Spinelli, N Salooja, G Sucak… in Bone Marrow Transplantation (2013)

  7. No Access

    Article

    Uptake and outcome of assisted reproductive techniques in long-term survivors of SCT

    We have audited the invitation for uptake and outcome of artificial reproductive techniques in patients undergoing SCT for haematological malignancy, with the aim of improving our pre-transplant counselling. A...

    A Babb, N Farah, C Lyons, K Lindsay, N Reddy, J Goldman… in Bone Marrow Transplantation (2012)